REGENERON PHARMACEUTICALS, INC. (REGN) Operating margin 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) operating margin by fiscal year — reported operating income divided by reported revenue.
24.9%FY2025 · since FY2016: 27.4% → 24.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 24.9% | -3.2 pp |
| FY2024 | 28.1% | -2.8 pp |
| FY2023 | 30.9% | -8.1 pp |
| FY2022 | 38.9% | -16.7 pp |
| FY2021 | 55.7% | +13.6 pp |
| FY2020 | 42.1% | +8.4 pp |
| FY2019 | 33.7% | -15.6 pp |
| FY2018 | 49.3% | +13.8 pp |
| FY2017 | 35.4% | +8.0 pp |
| FY2016 | 27.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice